Report Detail
Global Human Micobiome Market Growth (Status and Outlook) 2019-2024
- RnM2946779 |
- 15 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Other
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
According to this study, over the next five years the Human Micobiome market will register a 23.9% CAGR in terms of revenue, the global market size will reach US$ 610 million by 2024, from US$ 170 million in 2019. In particular, this report presents the global revenue market share of key companies in Human Micobiome business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Human Micobiome market by product type, application, key companies and key regions.
This study considers the Human Micobiome value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Treatment
Diagnosis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Micobiome market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Human Micobiome market by identifying its various subsegments.
Focuses on the key global Human Micobiome players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Micobiome with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Human Micobiome submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Human Micobiome Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human Micobiome Market Size 2014-2024
- 2.1.2 Human Micobiome Market Size CAGR by Region
- 2.2 Human Micobiome Segment by Type
- 2.2.1 Gastrointestinal Tract Human Micobiome
- 2.2.2 Urogenital Tract Human Micobiome
- 2.2.3 Other
- 2.3 Human Micobiome Market Size by Type
- 2.3.1 Global Human Micobiome Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Human Micobiome Market Size Growth Rate by Type (2014-2019)
- 2.4 Human Micobiome Segment by Application
- 2.4.1 Treatment
- 2.4.2 Diagnosis
- 2.5 Human Micobiome Market Size by Application
- 2.5.1 Global Human Micobiome Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Human Micobiome Market Size Growth Rate by Application (2014-2019)
3 Global Human Micobiome by Players
- 3.1 Global Human Micobiome Market Size Market Share by Players
- 3.1.1 Global Human Micobiome Market Size by Players (2017-2019)
- 3.1.2 Global Human Micobiome Market Size Market Share by Players (2017-2019)
- 3.2 Global Human Micobiome Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Human Micobiome by Regions
- 4.1 Human Micobiome Market Size by Regions
- 4.2 Americas Human Micobiome Market Size Growth
- 4.3 APAC Human Micobiome Market Size Growth
- 4.4 Europe Human Micobiome Market Size Growth
- 4.5 Middle East & Africa Human Micobiome Market Size Growth
5 Americas
- 5.1 Americas Human Micobiome Market Size by Countries
- 5.2 Americas Human Micobiome Market Size by Type
- 5.3 Americas Human Micobiome Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Human Micobiome Market Size by Countries
- 6.2 APAC Human Micobiome Market Size by Type
- 6.3 APAC Human Micobiome Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Human Micobiome by Countries
- 7.2 Europe Human Micobiome Market Size by Type
- 7.3 Europe Human Micobiome Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Human Micobiome by Countries
- 8.2 Middle East & Africa Human Micobiome Market Size by Type
- 8.3 Middle East & Africa Human Micobiome Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Human Micobiome Market Forecast
- 10.1 Global Human Micobiome Market Size Forecast (2019-2024)
- 10.2 Global Human Micobiome Forecast by Regions
- 10.2.1 Global Human Micobiome Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Human Micobiome Forecast by Type
- 10.8 Global Human Micobiome Forecast by Application
11 Key Players Analysis
- 11.1 Vedanta
- 11.1.1 Company Details
- 11.1.2 Human Micobiome Product Offered
- 11.1.3 Vedanta Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Vedanta News
- 11.2 Seres Therapeutics
- 11.2.1 Company Details
- 11.2.2 Human Micobiome Product Offered
- 11.2.3 Seres Therapeutics Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Seres Therapeutics News
- 11.3 Second Genome
- 11.3.1 Company Details
- 11.3.2 Human Micobiome Product Offered
- 11.3.3 Second Genome Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Second Genome News
- 11.4 Rebiotix
- 11.4.1 Company Details
- 11.4.2 Human Micobiome Product Offered
- 11.4.3 Rebiotix Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Rebiotix News
- 11.5 ActoGeniX
- 11.5.1 Company Details
- 11.5.2 Human Micobiome Product Offered
- 11.5.3 ActoGeniX Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 ActoGeniX News
- 11.6 Enterome BioScience
- 11.6.1 Company Details
- 11.6.2 Human Micobiome Product Offered
- 11.6.3 Enterome BioScience Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Enterome BioScience News
- 11.7 AvidBiotics
- 11.7.1 Company Details
- 11.7.2 Human Micobiome Product Offered
- 11.7.3 AvidBiotics Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 AvidBiotics News
- 11.8 4D Pharma Research Ltd
- 11.8.1 Company Details
- 11.8.2 Human Micobiome Product Offered
- 11.8.3 4D Pharma Research Ltd Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 4D Pharma Research Ltd News
- 11.9 Enterologics
- 11.9.1 Company Details
- 11.9.2 Human Micobiome Product Offered
- 11.9.3 Enterologics Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Enterologics News
- 11.10 Metabogen
- 11.10.1 Company Details
- 11.10.2 Human Micobiome Product Offered
- 11.10.3 Metabogen Human Micobiome Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Metabogen News
- 11.11 Metabiomics
- 11.12 Ritter Pharmaceuticals
- 11.13 Osel
- 11.14 Symberix
- 11.15 Miomics
- 11.16 Symbiotix Biotherapies
- 11.17 MicroBiome Therapeutics LLC
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Human Micobiome . Industry analysis & Market Report on Human Micobiome is a syndicated market report, published as Global Human Micobiome Market Growth (Status and Outlook) 2019-2024
. It is complete Research Study and Industry Analysis of Human Micobiome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
